Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Carter, Earl L. "Buddy" [R-GA-1]

Rep. Carter, Earl L. "Buddy" [R-GA-1]

United States · Official source

Records

2,145 records where Rep. Carter, Earl L. "Buddy" [R-GA-1] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 713 (118th)referred

Declaring War on the Cartels Act of 2023

United States · United States Congress · 1 February 2023

Declaring War on the Cartels Act of 2023 This bill enhances the term of federal imprisonment for members of certain transnational criminal cartels (i.e., Mexican cartels) who are repeat offenders. It also establishes penalties for U.S. banks and foreign governments that support or otherwise have dealings with these cartels. Specifically, cartel members are subject to an additional 10 to 20 years imprisonment if they are convicted of certain federal crimes (e.g., crimes of violence, fraud, or sexual exploitation) and have been previously convicted of similar crimes (including at the state or local level) within the last five years. Any U.S. national who is convicted as an accessory to such crimes is also subject to up to 15 years of additional imprisonment. The bill also prohibits cartel members from using U.S. banks to conduct business and subjects any related assets to federal seizure. Banks that intentionally do business with cartel members are subject to civil penalties. Additionally, the bill (1) bars noncitizen cartel members and their immediate family from admission into the United States, (2) authorizes sanctions against foreign governments and persons (individuals or entities) that support cartel activity, and (3) requires certain federal agencies to work with foreign governments on combatting cartels. The bill applies to members of the following cartels: The Sinaloa Cartel, The Jalisco New Generation Cartel, The Beltran-Leyva Cartel, The Gulf Cartel, The Los Zetas Cartel, The Tijuana Cartel, and The La Familia Michoacána/Knights Templar Cartel.

Bill· HRH.R. 734 (118th)open

Protection of Women and Girls in Sports Act of 2023

United States · United States Congress · 1 February 2023

Protection of Women and Girls in Sports Act of 2023 This bill generally prohibits school athletic programs from allowing individuals whose biological sex at birth was male to participate in programs that are for women or girls. Specifically, the bill provides that it is a violation of Title IX of the Education Amendments of 1972 for federally funded education programs or activities to operate, sponsor, or facilitate athletic programs or activities that allow individuals of the male sex to participate in programs or activities that are designated for women or girls. (Title IX prohibits discrimination on the basis of sex in federally funded education programs or activities, including in public elementary and secondary schools and in colleges and universities.) Under the bill, sex is based on an individual's reproductive biology and genetics at birth. The bill does not prohibit male individuals from training or practicing with programs or activities for women or girls as long as such training or practice does not deprive any female of corresponding opportunities or benefits.

Bill· HRH.R. 737 (118th)referred

Ralph David Abernathy, Sr. National Historic Site Act

United States · United States Congress · 1 February 2023

Ralph David Abernathy, Sr. National Historic Site Act This bill establishes the Ralph David Abernathy, Sr. National Historic Site in Georgia as a unit of the National Park System. The site shall preserve, protect, and interpret the area where the Reverend Dr. Abernathy served as pastor during the height of the modern civil rights movement and his role as an internationally recognized civil rights leader.

Bill· HRH.R. 726 (118th)referred

Veterans for Mustangs Act

United States · United States Congress · 1 February 2023

Veterans for Mustangs Act This bill directs the Department of the Interior to prioritize use of nonsurgical, medically safe on-range fertility controls to manage populations of wild, free-roaming horses and burros. In implementing such fertility controls, the Bureau of Land Management shall prioritize the recruitment of military veterans to train and become certified in the application of fertility controls, including the certified PZP applicator certification offered by the Science and Conservation Center's Certification Program. Interior shall provide appropriate compensation to military veterans participating in such a certification program. The bill authorizes Interior to contract with military veterans who have completed the training program to carry out fertility control activities.

Bill· HRH.R. 700 (118th)referred

Supply Chain Disruptions Relief Act

United States · United States Congress · 1 February 2023

Supply Chain Disruptions Relief Act This bill modifies the treatment of liquidations of new motor vehicle inventory as qualified LIFO (last in first out accounting method) inventory. It allows new motor vehicle dealers to elect to wait until the end of 2025 to replace their inventory for purposes of determining income attributable to the sale of such inventory during 2020 and 2021.

Bill· HRH.R. 655 (118th)referred

Disaster Reforestation Act

United States · United States Congress · 31 January 2023

Disaster Reforestation Act This bill sets forth a special rule for the tax deduction for casualty losses of uncut timber (including pre-merchantable timber). It provides that in losses of any uncut timber from fire, storm, insects, invasive species, drought, or other casualty, or from theft, the basis for determining the amount of the deduction for such loss shall not be less than the excess of the value of such timber determined immediately before such loss was sustained, over the salvage value of such timber. To be eligible for the casualty loss deduction, the uncut timber subject to the loss must be reforested not later than the close of the five-year period beginning on the date of the loss.

Bill· HRH.R. 619 (118th)open

NAPA Reauthorization Act

United States · United States Congress · 30 January 2023

NAPA Reauthorization Act This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias. In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline. The bill also expands the Advisory Council on Alzheimer's Research, Care, and Services to include additional members, such as (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice and the Office of Management and Budget).

Bill· HRH.R. 621 (118th)referred

PART Act

United States · United States Congress · 30 January 2023

Preventing Auto Recycling Theft Act or the PART Act This bill establishes requirements for motor vehicles related to catalytic converters and other motor vehicle parts that contain precious metals. The National Highway Traffic Safety Administration must revise the motor vehicle theft prevention standard for new motor vehicles to include catalytic converters among the parts that require an inscribed or affixed identifying number. Additionally, the Department of Transportation must establish a grant program through which law enforcement agencies and other entities can stamp vehicle identification numbers onto catalytic converters of existing vehicles. The bill establishes retention requirements for the purchase of motor vehicle parts that contain precious metals. It also sets forth criminal penalties for the theft of catalytic converters or any precious metals removed from a vehicle.

Bill· HRH.R. 624 (118th)referred

Recognizing Victims of Illicit Fentanyl Poisoning Act

United States · United States Congress · 30 January 2023

Recognizing Victims of Illicit Fentanyl Poisoning Act This bill authorizes states and territories that receive victim compensation grant funds to use the grant funds to compensate an additional category of individuals. Specifically, current law requires states and territories to use formula grant funds to compensate victims and survivors for expenses attributable to a physical injury or death resulting from a compensable crime. This bill broadens the meaning of the term compensable crime to include illicit fentanyl poisoning resulting in death.

Bill· HRH.R. 589 (118th)referred

MAHSA Act

United States · United States Congress · 27 January 2023

Mahsa Amini Human rights and Security Accountability Act or the MAHSA Act This bill requires the President to impose property- and visa-blocking sanctions on certain persons (individuals and entities) affiliated with Iran. The President must periodically make determinations about whether certain existing sanctions apply to specified persons and impose the applicable sanctions, including determinations concerning (1) the Supreme Leader of Iran and any official in the Office of the Supreme Leader of Iran, (2) the President of Iran and any official in the Office of the President of Iran, and (3) any entity overseen by the Office of the Supreme Leader of Iran which is complicit in supporting human rights abuses or terrorism.

Bill· HRH.R. 615 (118th)referred

Protecting Access for Hunters and Anglers Act of 2023

United States · United States Congress · 27 January 2023

Protecting Access for Hunters and Anglers Act of 2023 This bill bars the Department of the Interior and the Department of Agriculture from prohibiting or regulating the use of lead ammunition or tackle on federal land or water that is under the jurisdiction of such departments and made available for hunting or fishing. The bill makes exceptions for specified existing regulations and where the applicable department determines that a decline in wildlife population at the specific unit of federal land or water is primarily caused by the use of lead in ammunition or tackle, based on the field data from such unit, and the state approves the regulations.

Bill· HRH.R. 549 (118th)referred

Metastatic Breast Cancer Access to Care Act

United States · United States Congress · 26 January 2023

Metastatic Breast Cancer Access to Care Act This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). Specifically, the bill eliminates the 5-month waiting period for SSDI benefits and the subsequent 24-month waiting period for Medicare coverage for individuals with metastatic breast cancer. Under current law, individuals generally must wait 5 months after the onset of disability to begin receiving SSDI benefits and an additional 24 months to become eligible for Medicare.

Bill· HRH.R. 537 (118th)referred

Forgotten Heroes of the Holocaust Congressional Gold Medal Act

United States · United States Congress · 26 January 2023

Forgotten Heroes of the Holocaust Congressional Gold Medal Act This bill provides for the award of a Congressional Gold Medal to 60 diplomats posthumously in recognition of their brave and vital service of saving Jews during World War II.

Bill· HRH.R. 582 (118th)referred

Credit Union Board Modernization Act

United States · United States Congress · 26 January 2023

Credit Union Board Modernization Act This bill revises the required frequency of meetings held by a credit union's board of directors. Specifically, new credit unions and credit unions with a low soundness rating must meet monthly. All other credit unions must hold at least six meetings annually, with at least one meeting held during each fiscal quarter. Currently, all credit union boards must meet at least once a month.

Bill· HRH.R. 564 (118th)referred

Saving Taxpayers’ Money and Paying America’s Debt Act

United States · United States Congress · 26 January 2023

Saving Taxpayers' Money and Paying America's Debt Act This bill rescinds unobligated funds that were provided by the American Rescue Plan Act of 2021 and requires the funds to be used for the sole purpose of deficit reduction. (The American Rescue Plan Act of 2021 provided funding to address the impact of COVID-19 on the economy, public health, state and local governments, individuals, and businesses.)

Bill· HRH.R. 531 (118th)referred

Educational Choice for Children Act

United States · United States Congress · 26 January 2023

Educational Choice for Children Act This bill allows individuals and corporations a new tax credit after 2023 for charitable contributions to tax-exempt organizations that provide scholarships to elementary and secondary school students. Such students must be members of a household with incomes not greater 300% of the area median gross income and be eligible to enroll in a public elementary or secondary school. The bill excludes from the gross income of taxpayer dependents any scholarship amount for the elementary or secondary education expenses of eligible students. It also prohibits governmental control over scholarship granting organizations.

Bill· HRH.R. 497 (118th)referred

Freedom for Health Care Workers Act

United States · United States Congress · 25 January 2023

Freedom for Health Care Workers Act This bill nullifies the rule titled Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination , which was issued by the Centers for Medicare & Medicaid Services on November 5, 2021, and prohibits the issuance of any substantially similar rule. The rule requires health care providers, as a condition of Medicare and Medicaid participation, to ensure that staff are fully vaccinated against COVID-19.

Resolution· HCONRESH.Con.Res. 10 (118th)referred

Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations.

United States · United States Congress · 25 January 2023

This concurrent resolution calls on the President to abandon the One China policy in favor of one that recognizes Taiwan as an independent country that is not a part of China. The resolution also urges the President to bolster diplomatic and economic relations between the United States and Taiwan through specified means.

Bill· HRH.R. 506 (118th)referred

HARM Act

United States · United States Congress · 25 January 2023

Holding Accountable Russian Mercenaries Act or the HARM Act This bill requires the Department of State to designate the Wagner Group as a foreign terrorist organization. Such designation also applies to any affiliated and successor entities undertaking malign activities against the United States and its allies or partners. (Among other things, such a designation allows the Department of the Treasury to require financial institutions to block transactions involving the organization.) The President may waive the application of sanctions against these entities if the President determines it to be in the national interest.

Bill· HRH.R. 485 (118th)referred

Protecting Health Care for All Patients Act of 2023

United States · United States Congress · 24 January 2023

Protecting Health Care for All Patients Act of 2023 This bill prohibits all federal health care programs, including the Federal Employees Health Benefits Program, and federally funded state health care programs (e.g., Medicaid) from using prices that are based on quality-adjusted life years (i.e., measures that discount the value of a life based on disability) to determine relevant thresholds for coverage, reimbursements, or incentive programs.

Bill· HRH.R. 467 (118th)referred

HALT Fentanyl Act

United States · United States Congress · 24 January 2023

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Bill· HRH.R. 456 (118th)referred

Fairness in Orphan Drug Exclusivity Act

United States · United States Congress · 24 January 2023

Fairness in Orphan Drug Exclusivity Act This bill limits which orphan drugs may be granted a market exclusivity period by the Food and Drug Administration (FDA). (Generally, an orphan drug is one that is not economically viable because of the rarity of the disease that it treats; the sponsor of an FDA-designated orphan drug may be granted various incentives, such as a seven-year period in which the FDA may not grant market approval to a different sponsor for the same drug to treat the same disease.) Under this bill, if a drug is designated as an orphan drug on the basis that there is no reasonable expectation that the sponsor will recover the costs of developing and distributing the drug from U.S. sales, the drug shall be granted the seven-year exclusivity period only if the sponsor demonstrates that there is no reasonable expectation that it will recover such costs within its first 12 years of U.S. sales of the drug. When deciding whether an orphan drug meets this requirement, the FDA shall consider the sales of all drugs from the sponsor that are covered by the same orphan drug designation.

Bill· HRH.R. 484 (118th)referred

Natural Gas Tax Repeal Act

United States · United States Congress · 24 January 2023

Natural Gas Tax Repeal Act This bill eliminates a program administered by the Environmental Protection Agency (EPA) that provides incentives for petroleum and natural gas systems to reduce their emissions of methane and other greenhouse gases. It also repeals a charge on methane emissions from specific types of facilities that are required to report their greenhouse gas emissions to the EPA's Greenhouse Gas Emissions Reporting Program.

Bill· HRH.R. 448 (118th)referred

Putting Investors First Act of 2023

United States · United States Congress · 24 January 2023

Putting Investors First Act of 2023 This bill requires a proxy advisory firm to register with the Securities and Exchange Commission and prohibits an unregistered proxy advisory firm from using interstate commerce to provide proxy-voting advice, research, analysis, or recommendations to any client. With respect to these firms, the bill (1) establishes procedures for both registration and termination of registration; (2) requires each firm to employ an ombudsman, designate a compliance officer, and publicly disclose conflicts of interest; (3) allows issuers to assess and comment on proxy voting recommendations; and (4) prohibits unfair, coercive, or abusive practices. The bill establishes a private right of action against a proxy advisory firm that endorses an approved proposal that is not supported by the issuer and is found to be illegal.

Bill· HRH.R. 407 (118th)referred

Protect the UNBORN Act

United States · United States Congress · 20 January 2023

Protect the UNBORN (Undo the Negligent Biden Orders Right Now) Act or the Protect the UNBORN Act This bill prohibits federal implementation of and funding for specified executive orders that address access to reproductive health care services, including services related to pregnancy or the termination of a pregnancy.

Bill· HRH.R. 427 (118th)referred

SAVE Moms and Babies Act of 2023

United States · United States Congress · 20 January 2023

Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

Bill· HRH.R. 405 (118th)referred

Essential Medicines Strategic Stockpile Act of 2023

United States · United States Congress · 20 January 2023

Essential Medicines Strategic Stockpile Act of 2023 This bill requires the Department of Health and Human Services (HHS) to create a pilot program to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. To carry out the pilot program, HHS must enter into contracts for a term of up to three years with drug manufacturers, co-op or chain pharmacy warehouses, or other eligible entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.

Bill· HRH.R. 414 (118th)referred

Investing in Rural Manufacturing Act

United States · United States Congress · 20 January 2023

Investing in Rural Manufacturing Act This bill authorizes the Small Business Administration to make loans for certain costs to businesses that manufacture goods essential to critical infrastructure sectors in rural areas. Businesses that meet at least 75% of their job creation goals under such loans may receive partial loan forgiveness.

Bill· HRH.R. 431 (118th)referred

Life at Conception Act

United States · United States Congress · 20 January 2023

Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.

Resolution· HRESH.Res. 50 (118th)referred

Recognizing that article I, section 10 of the United States Constitution explicitly reserves to the States the sovereign power to repel an invasion and defend their citizenry from the overwhelming and "imminent danger" posed by paramilitary, narco-terrorist cartels, terrorists and criminal actors who have seized control of our southern border.

United States · United States Congress · 20 January 2023

This resolution declares that every state within the United States has the sovereign right to exclude any person who does not have the right to be there. It also declares that the states along the southern border (1) are being invaded by terrorists, narco-terrorist cartels, and criminal actors; and (2) have the sovereign and unilateral authority to defend themselves against such an invasion.

Bill· HRH.R. 382 (118th)referred

Pandemic is Over Act

United States · United States Congress · 17 January 2023

Pandemic is Over Act This bill terminates the COVID-19 public health emergency that was declared on January 31, 2020, on the date of the bill's enactment.

Bill· HRH.R. 372 (118th)referred

Protecting Life and Taxpayers Act of 2023

United States · United States Congress · 17 January 2023

Protecting Life and Taxpayers Act of 2023 This bill requires federally funded entities to certify that they will not, subject to certain exceptions, perform abortions or provide funding to other entities that perform abortions. The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness.

Bill· HRH.R. 383 (118th)referred

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

United States · United States Congress · 17 January 2023

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

Bill· HRH.R. 371 (118th)referred

Defund Planned Parenthood Act of 2023

United States · United States Congress · 17 January 2023

Defund Planned Parenthood Act of 2023 This bill restricts federal funding for Planned Parenthood Federation of America Inc. or any of its affiliates or clinics for one year. Specifically, it prohibits funding those entities unless they certify that the affiliates and clinics will not perform, and will not provide funds to entities that perform, abortions during that year. If the certification requirement is not met, the Department of Health and Human Services and the Department of Agriculture must recoup any federal assistance received by those entities. However, the bill's funding restriction does not apply to abortions performed in cases of rape or incest or when necessary to resolve a physical condition that endangers a woman's life. The bill also provides additional funding for community health centers for the one-year period. These funds are subject to the same abortion-related restrictions and exceptions.

Bill· HRH.R. 397 (118th)referred

GORAC Act

United States · United States Congress · 17 January 2023

Government Office Realignment And Closure Act of 2023 or the GORAC Act This bill directs the Government Accountability Office (GAO) to provide for an independent evaluation of federal agencies and programs to identify duplicative, wasteful, or outdated functions and provides for congressional consideration of legislation to implement recommendations from the evaluation. Specifically, the GAO must (1) procure the services of a nonfederal auditor to evaluate each federal program carried out in the previous 20 years, make recommendations on federal agencies and programs that should be realigned or eliminated, and report on such recommendations; and (2) take steps to assure that any work performed by such auditor complies with standards established by the GAO for audits of federal establishments, programs, activities, and functions. The GAO must provide for the relocation of federal employees whose positions are eliminated as a result of the implementation of recommendations included in the report.

Bill· HRH.R. 385 (118th)referred

No User Fees for Gun Owners Act

United States · United States Congress · 17 January 2023

No User Fees for Gun Owners Act This bill prohibits a state or local government from imposing any insurance requirement, tax, user fee, or similar charge as a condition of the manufacture importation, acquisition, transfer, or continued ownership of a firearm or ammunition, with the exception of a proportionate sales tax. The bill imposes the same prohibition under the Internal Revenue Code for firearms, pistols, or revolvers, but allows for the assessment of a proportionate sales tax.

Bill· HRH.R. 354 (118th)referred

LEOSA Reform Act of 2024

United States · United States Congress · 13 January 2023

LEOSA Reform Act This bill broadens the authority for certain law enforcement officers to carry concealed firearms across state lines. Specifically, the bill allows qualified active and retired law enforcement officers to carry concealed firearms and ammunition (including magazines) in school zones; in national parks; on state, local, or private property that is open to the public; and in certain federal facilities that are open to the public. Further, the bill permits states to reduce the frequency with which retired law enforcement officers must meet certain qualification standards.

Bill· HRH.R. 347 (118th)open

Reduce Exacerbated Inflation Negatively Impacting the Nation Act

United States · United States Congress · 12 January 2023

Reduce Exacerbated Inflation Negatively Impacting the Nation Act This bill requires the Office of Management and Budget and the Council of Economic Advisers to provide an inflation estimate for each executive order that is projected to cause an annual gross budgetary effect of at least $1 billion. The estimate must determine whether the executive order will have no significant impact on inflation, a quantifiable inflationary impact on the Consumer Price Index, or a significant impact on inflation that cannot be quantified at the time the estimate is prepared. The requirement does not apply to executive orders that (1) provide for emergency assistance or relief at the request of any state or local government or an official of the government, or (2) are necessary for national security or the ratification or implementation of international treaty obligations.

Bill· HRH.R. 336 (118th)referred

Finish the Wall Act

United States · United States Congress · 12 January 2023

Finish the Wall Act This bill requires the Department of Homeland Security (DHS) to resume activities related to the construction of a barrier system along the U.S.-Mexico border and addresses other border-related issues. DHS must resume all such construction activities that were planned or underway prior to January 20, 2021. DHS must also expend all funds appropriated or explicitly obligated since October 1, 2016, for construction of this barrier system. DHS may not cancel contracts for activities related to such construction entered into on or before January 20, 2021. Furthermore, within 14 days of this bill's enactment, DHS must certify to Congress that U.S. Customs and Border Protection facilities that process adults taken into custody at the border are fully compliant with certain laws related to the collection of DNA. (Among other things, these laws allow for the collection of DNA samples from non-U.S. persons detained under U.S. authority.)

Bill· HJRESH.J.Res. 18 (118th)referred

AUMF CARTEL Influence Resolution

United States · United States Congress · 12 January 2023

Authorization for the Use of Military Force to Combat, Attack, Resist, Target, Eliminate, and Limit Influence Resolution or the AUMF CARTEL Influence Resolution This joint resolution authorizes the President to use the Armed Forces against foreign nations, foreign organizations, or foreign persons affiliated with foreign organizations that the President determines are involved in trafficking fentanyl or fentanyl-related substances into the United States. The joint resolution also authorizes the use of force against those determined to have used force or violence in specified ways, such as engaging in violence or intimidation to control territory to be used for illicit means. The joint resolution deems nine named cartels as having met the criteria for the President to use force against them. Force authorized by this joint resolution may only be used against organizations and persons located outside of the United States. The authority expires five years after the date of this joint resolution's enactment.

Bill· HRH.R. 311 (118th)referred

Cost Estimates Improvement Act

United States · United States Congress · 12 January 2023

Cost Estimates Improvement Act This bill requires cost estimates prepared by the Congressional Budget Office or the Joint Committee on Taxation to include (1) the cost of servicing the public debt; and (2) a list of any federal agencies, programs, and initiatives with fragmented, overlapping, or duplicative goals or activities covered by the legislation.

Bill· HRH.R. 317 (118th)referred

SEC Act of 2023

United States · United States Congress · 12 January 2023

Stop Environmental Calculations Act of 2023 or the SEC Act of 2023 This bill prohibits the Securities and Exchange Commission from requiring climate-related disclosures that are not material to investors.

Bill· HRH.R. 277 (118th)open

Regulations from the Executive in Need of Scrutiny Act of 2023

United States · United States Congress · 11 January 2023

Regulations from the Executive in Need of Scrutiny Act of 20 23 This bill revises provisions relating to congressional review of agency rulemaking. Specifically, the bill establishes a congressional approval process for a major rule. A major rule may only take effect if Congress approves of the rule. A major rule is a rule that has resulted in or is likely to result in (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices for consumers, individual industries, government agencies, or geographic regions; or (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete with foreign-based enterprises. The bill generally preserves the current congressional review process for a nonmajor rule.

Bill· HRH.R. 279 (118th)referred

Pharmacist Conscience Protection Act

United States · United States Congress · 11 January 2023

Pharmacist Conscience Protection Act This bill prohibits the federal government and federally funded entities from discriminating or otherwise taking adverse action against a pharmacist, pharmacy owner, or pharmacy technician who declines to store, fill prescriptions for, or make referrals for drugs that cause abortions (or that the individual provider believes in good faith cause abortions). Individuals or the Department of Justice may bring civil actions for violations of this bill.

Bill· HRH.R. 7 (118th)referred

No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023

United States · United States Congress · 9 January 2023

No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023 This bill modifies provisions relating to federal funding for, and health insurance coverage of, abortions. Specifically, the bill prohibits the use of federal funds for abortions or for health coverage that includes abortions. Such restrictions extend to the use of funds in the budget of the District of Columbia. Additionally, abortions may not be provided in a federal health care facility or by a federal employee. Historically, language has been included in annual appropriations bills for the Department of Health and Human Services (HHS) that prohibits the use of federal funds for abortions—such language is commonly referred to as the Hyde Amendment. Similar language is also frequently included in appropriations bills for other federal agencies and the District of Columbia. The bill makes these restrictions permanent and extends the restrictions to all federal funds (rather than specific agencies). The bill's restrictions regarding the use of federal funds do not apply in cases of rape, incest, or where a physical disorder, injury, or illness endangers a woman's life unless an abortion is performed. The Hyde Amendment provides the same exceptions. The bill also prohibits qualified health plans from including coverage for abortions. Currently, qualified health plans may cover abortion, but the portion of the premium attributable to abortion coverage is not eligible for subsidies.

Bill· HRH.R. 152 (118th)referred

Hearing Protection Act

United States · United States Congress · 9 January 2023

Hearing Protection Act This bill removes silencers from the definition of firearms for purposes of the National Firearms Act. It also treats persons acquiring or possessing a firearm silencer as meeting any registration and licensing requirements of such Act. The Department of Justice must destroy certain records relating to the registration, transfer, or making of a silencer. The bill also revises the definitions of firearm silencer and firearm muffler under the federal criminal code and includes such items in the 10% excise tax category.

Bill· HRH.R. 29 (118th)referred

Border Safety and Security Act of 2023

United States · United States Congress · 9 January 2023

Border Safety and Security Act of 2023 This bill requires the Department of Homeland Security (DHS) to suspend the entry of any non-U.S. nationals ( aliens under federal law) without valid entry documents during any period when DHS cannot detain such an individual or return the individual to a foreign country contiguous to the United States. A state may sue DHS to enforce this requirement. (Under current law, non-U.S. nationals who arrive at the border without entry documents are generally subject to expedited removal. However, if such an individual is found to have a credible fear of persecution, they are typically subject to detention while their asylum claim is being considered.) The bill also authorizes DHS to suspend the entry of non-U.S. nationals without entry documents at the border if DHS determines that such a suspension is necessary to achieve operational control over such a border.